1-181483800-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2

The NM_001205293.3(CACNA1E):​c.56C>T​(p.Ser19Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000316 in 1,612,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S19W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000033 ( 0 hom. )

Consequence

CACNA1E
NM_001205293.3 missense

Scores

1
12
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 3.94
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.41716638).
BP6
Variant 1-181483800-C-T is Benign according to our data. Variant chr1-181483800-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1578107.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1, Benign=1}.
BS2
High AC in GnomAdExome4 at 48 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.56C>T p.Ser19Leu missense_variant Exon 1 of 48 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.56C>T p.Ser19Leu missense_variant Exon 1 of 48 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.56C>T p.Ser19Leu missense_variant Exon 1 of 47 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.56C>T p.Ser19Leu missense_variant Exon 1 of 47 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.56C>T p.Ser19Leu missense_variant Exon 1 of 46 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.491C>T p.Ser164Leu missense_variant Exon 3 of 12 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151896
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000481
GnomAD2 exomes
AF:
0.0000201
AC:
5
AN:
248554
AF XY:
0.0000222
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000267
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000329
AC:
48
AN:
1461052
Hom.:
0
Cov.:
31
AF XY:
0.0000399
AC XY:
29
AN XY:
726818
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33454
American (AMR)
AF:
0.00
AC:
0
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53360
Middle Eastern (MID)
AF:
0.000178
AC:
1
AN:
5614
European-Non Finnish (NFE)
AF:
0.0000180
AC:
20
AN:
1111536
Other (OTH)
AF:
0.0000994
AC:
6
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151896
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74162
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41364
American (AMR)
AF:
0.00
AC:
0
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5118
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67988
Other (OTH)
AF:
0.000481
AC:
1
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000659
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.0000166
AC:
2
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 69 Uncertain:1
Mar 21, 2022
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 26, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Jan 05, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Uncertain
0.046
T
BayesDel_noAF
Uncertain
0.010
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.37
.;.;.;.;T;T;.;T;.
Eigen
Uncertain
0.21
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.93
D;.;.;D;.;D;D;D;D
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.42
T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.78
D
MutationAssessor
Benign
1.1
.;L;L;.;L;.;L;L;L
PhyloP100
3.9
PrimateAI
Uncertain
0.70
T
PROVEAN
Uncertain
-2.6
.;D;.;D;D;D;.;.;D
REVEL
Uncertain
0.45
Sift
Uncertain
0.010
.;D;.;D;D;D;.;.;D
Sift4G
Benign
0.099
.;T;T;T;T;T;T;T;T
Polyphen
0.52
.;P;.;.;.;.;P;.;.
Vest4
0.21, 0.21, 0.25, 0.28, 0.24, 0.27, 0.24, 0.31
MVP
0.79
MPC
1.3
ClinPred
0.31
T
GERP RS
5.3
PromoterAI
-0.015
Neutral
Varity_R
0.28
gMVP
0.40
Mutation Taster
=234/66
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs758128368; hg19: chr1-181452936; COSMIC: COSV62398405; API